An open-label pilot study of the effectiveness of adalimumab in patients with rheumatoid arthritis and previous infliximab treatment: relationship to reasons for failure and anti-infliximab antibody status
2008 · Clinical Rheumatology · 83 citations
https://doi.org/10.1007/s10067-008-0866-4